These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 14662871)
1. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. LeBouder E; Rey-Nores JE; Rushmere NK; Grigorov M; Lawn SD; Affolter M; Griffin GE; Ferrara P; Schiffrin EJ; Morgan BP; Labéta MO J Immunol; 2003 Dec; 171(12):6680-9. PubMed ID: 14662871 [TBL] [Abstract][Full Text] [Related]
2. TLR2 recognizes a bacterial lipopeptide through direct binding. Vasselon T; Detmers PA; Charron D; Haziot A J Immunol; 2004 Dec; 173(12):7401-5. PubMed ID: 15585865 [TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production. Langjahr P; Díaz-Jiménez D; De la Fuente M; Rubio E; Golenbock D; Bronfman FC; Quera R; González MJ; Hermoso MA PLoS One; 2014; 9(12):e104624. PubMed ID: 25531754 [TBL] [Abstract][Full Text] [Related]
4. Soluble TLR2 reduces inflammation without compromising bacterial clearance by disrupting TLR2 triggering. Raby AC; Le Bouder E; Colmont C; Davies J; Richards P; Coles B; George CH; Jones SA; Brennan P; Topley N; Labéta MO J Immunol; 2009 Jul; 183(1):506-17. PubMed ID: 19542461 [TBL] [Abstract][Full Text] [Related]
5. Soluble TLR2 is present in human amniotic fluid and modulates the intraamniotic inflammatory response to infection. Dulay AT; Buhimschi CS; Zhao G; Oliver EA; Mbele A; Jing S; Buhimschi IA J Immunol; 2009 Jun; 182(11):7244-53. PubMed ID: 19454721 [TBL] [Abstract][Full Text] [Related]
6. Interaction of soluble form of recombinant extracellular TLR4 domain with MD-2 enables lipopolysaccharide binding and attenuates TLR4-mediated signaling. Hyakushima N; Mitsuzawa H; Nishitani C; Sano H; Kuronuma K; Konishi M; Himi T; Miyake K; Kuroki Y J Immunol; 2004 Dec; 173(11):6949-54. PubMed ID: 15557191 [TBL] [Abstract][Full Text] [Related]
7. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. Bulut Y; Faure E; Thomas L; Equils O; Arditi M J Immunol; 2001 Jul; 167(2):987-94. PubMed ID: 11441107 [TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. Parker LC; Whyte MK; Vogel SN; Dower SK; Sabroe I J Immunol; 2004 Apr; 172(8):4977-86. PubMed ID: 15067079 [TBL] [Abstract][Full Text] [Related]
9. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. Levy O; Zarember KA; Roy RM; Cywes C; Godowski PJ; Wessels MR J Immunol; 2004 Oct; 173(7):4627-34. PubMed ID: 15383597 [TBL] [Abstract][Full Text] [Related]
10. Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. Henrick BM; Nag K; Yao XD; Drannik AG; Aldrovandi GM; Rosenthal KL PLoS One; 2012; 7(7):e40138. PubMed ID: 22792230 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. Shoham S; Huang C; Chen JM; Golenbock DT; Levitz SM J Immunol; 2001 Apr; 166(7):4620-6. PubMed ID: 11254720 [TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. Tapping RI; Akashi S; Miyake K; Godowski PJ; Tobias PS J Immunol; 2000 Nov; 165(10):5780-7. PubMed ID: 11067937 [TBL] [Abstract][Full Text] [Related]
14. Soluble toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection. Henrick BM; Yao XD; Drannik AG; Abimiku A; Rosenthal KL; AIDS; 2014 Sep; 28(14):2023-32. PubMed ID: 25265071 [TBL] [Abstract][Full Text] [Related]
15. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. Sato M; Sano H; Iwaki D; Kudo K; Konishi M; Takahashi H; Takahashi T; Imaizumi H; Asai Y; Kuroki Y J Immunol; 2003 Jul; 171(1):417-25. PubMed ID: 12817025 [TBL] [Abstract][Full Text] [Related]
16. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Dybdahl B; Wahba A; Lien E; Flo TH; Waage A; Qureshi N; Sellevold OF; Espevik T; Sundan A Circulation; 2002 Feb; 105(6):685-90. PubMed ID: 11839622 [TBL] [Abstract][Full Text] [Related]
17. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Kuroishi T; Tanaka Y; Sakai A; Sugawara Y; Komine K; Sugawara S Mol Immunol; 2007 Mar; 44(8):1969-76. PubMed ID: 17081611 [TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970 [TBL] [Abstract][Full Text] [Related]
19. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. Wyllie DH; Kiss-Toth E; Visintin A; Smith SC; Boussouf S; Segal DM; Duff GW; Dower SK J Immunol; 2000 Dec; 165(12):7125-32. PubMed ID: 11120843 [TBL] [Abstract][Full Text] [Related]
20. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. Melmed G; Thomas LS; Lee N; Tesfay SY; Lukasek K; Michelsen KS; Zhou Y; Hu B; Arditi M; Abreu MT J Immunol; 2003 Feb; 170(3):1406-15. PubMed ID: 12538701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]